Zhou Deng

Title: Zhou Deng: Innovator in Pharmaceutical Compounds

Introduction

Zhou Deng is a prominent inventor based in Xiamen, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating tumors and other diseases. With a total of 3 patents to his name, his work is recognized for its potential impact on medical treatments.

Latest Patents

Zhou Deng's latest patents include innovative compounds and their applications. One of his notable inventions is a substituted aryl ether compound, which is designed for use in pharmaceutical compositions aimed at preventing or treating tumors. This invention encompasses a compound with a specific formula, including its stereoisomers, prodrugs, and pharmaceutically acceptable salts.

Another significant patent is for a thienopyrimidine compound, which exhibits selective inhibitory activity against ALK and/or c-Met. This compound is crucial for developing medications that target diseases associated with anaplastic lymphoma kinase and cancer metastasis. The preparation method and pharmaceutical applications of this compound further highlight Zhou Deng's expertise in medicinal chemistry.

Career Highlights

Zhou Deng has worked with esteemed institutions such as Xiamen University and Hongyun Biotech Co., Ltd. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in pharmaceuticals.

Collaborations

Throughout his career, Zhou has collaborated with notable colleagues, including Xianming Deng and Zhiyu Hu. These partnerships have fostered a productive environment for innovation and development in pharmaceutical research.

Conclusion

Zhou Deng's contributions to the field of pharmaceuticals through his patents and collaborations demonstrate his commitment to advancing medical science. His work continues to pave the way for new treatments that can significantly improve patient outcomes.